RPRX

36.24

1.43% 0.51

Dopo l'orario di chiusura: 36.15 -0.09 -0.25%

Royalty Pharma Plc (RPRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$35.73

Aprire:

$36.02

Volume 24 ore:

13.87M

Relative Volume:

3.64

Capitalizzazione di mercato:

$15.67B

Reddito:

$2.31B

Utile/perdita netta:

$1.66B

Rapporto P/E:

15.76

EPS:

2.3

Flusso di cassa netto:

$827.02M

1 W Prestazione:

-0.33%

1M Prestazione:

+0.67%

6M Prestazione:

+8.47%

1 anno Prestazione:

+29.47%

Intervallo 1D:

$35.78

$36.65

Intervallo di 1 settimana:

$34.84

$36.65

Portata 52W:

$24.05

$38.00

Royalty Pharma Plc Stock (RPRX) Company Profile

Nome

Royalty Pharma Plc

Settore

Healthcare (1154)

Industria

Biotechnology (647)

Telefono

(212) 883-0200

Indirizzo

110 EAST 59TH STREET, NEW YORK, NY

Dipendente

Cinguettio

Prossima data di guadagno

2025-02-11

Ultimi documenti SEC

RPRX's Discussions on Twitter

Confronta RPRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RPRX Royalty Pharma Plc	36.24	15.45B	2.31B	1.66B	827.02M	2.30
VRTX Vertex Pharmaceuticals Inc	383.12	99.25B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	591.99	63.46B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	453.56	59.27B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	736.76	44.78B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	334.40	37.75B	3.81B	-644.79M	-669.77M	-6.24

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-16	Iniziato	Morgan Stanley	Overweight
2024-06-03	Downgrade	UBS	Buy → Neutral
2022-06-14	Ripresa	UBS	Buy
2022-05-13	Iniziato	Scotiabank	Sector Outperform
2022-04-27	Iniziato	Goldman	Buy
2022-04-14	Aggiornamento	JP Morgan	Neutral → Overweight
2022-04-06	Ripresa	Morgan Stanley	Overweight
2021-10-29	Aggiornamento	Citigroup	Neutral → Buy
2021-07-30	Iniziato	Tigress Financial	Buy
2020-11-09	Aggiornamento	UBS	Neutral → Buy
2020-07-14	Iniziato	Evercore ISI	In-line
2020-07-13	Iniziato	BofA Securities	Buy
2020-07-13	Iniziato	Citigroup	Neutral
2020-07-13	Iniziato	Cowen	Outperform
2020-07-13	Iniziato	Goldman	Neutral
2020-07-13	Iniziato	JP Morgan	Neutral
2020-07-13	Iniziato	Morgan Stanley	Equal-Weight
2020-07-13	Iniziato	SunTrust	Buy
2020-07-13	Iniziato	UBS	Neutral

Mostra tutto

Royalty Pharma Plc Borsa (RPRX) Ultime notizie

05:11 AM

Strs Ohio Invests $1.89 Million in Royalty Pharma PLC $RPRX - MarketBeat

05:11 AM

Sep 19, 2025

Pacific Capital Partners Ltd Sells 77,500 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 19, 2025

Sell Signal: Does HAIN align with a passive investing strategyPortfolio Gains Report & Fast Momentum Entry Tips - khodrobank.com

Sep 19, 2025

Analyst Downgrade: Why is Royalty Pharma plc stock going downJuly 2025 Trends & AI Enhanced Trading Alerts - khodrobank.com

Sep 19, 2025

Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today - Sahm

Sep 19, 2025

Understanding Royalty Pharma plc’s price movementJuly 2025 Trends & Short-Term Swing Trade Alerts - newser.com

Sep 19, 2025

Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum - The Manila Times

Sep 19, 2025

Leading Biopharma Royalty Investor Royalty Pharma Featured at Bernstein Healthcare Forum 2025 - Stock Titan

Sep 19, 2025

Layoff Watch: Will Royalty Pharma plc benefit from rate cutsWeekly Trend Recap & Stock Market Timing Techniques - khodrobank.com

Sep 19, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 226,048 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 19, 2025

Sep 18, 2025

Market Outlook: Should I buy Royalty Pharma plc stock now2025 Market Overview & Daily Entry Point Alerts - khodrobank.com

Sep 18, 2025

Royalty Pharma (NASDAQ:RPRX) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Sep 18, 2025

Nasdaq Moves: What are the analyst revisions for GCLWWIs Royalty Pharma plc stock a good investment in YEARJuly 2025 Macro Moves & Verified Chart Pattern Trade Signals - khodrobank.com

Sep 18, 2025

Sep 17, 2025

Royalty Pharma’s $2 Billion Debt Offering Could Be a Game Changer for RPRX - simplywall.st

Sep 17, 2025

TD Cowen Maintains a Buy on Royalty Pharma (RPRX) - Insider Monkey

Sep 17, 2025

Royalty Pharma Plc Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo

Sep 17, 2025

Gainers Report: Will Royalty Pharma plc outperform the market in YEARMarket Sentiment Summary & Stock Timing and Entry Methods - خودرو بانک

Sep 16, 2025

Royalty Pharma stock price target raised to $38 from $37 at UBS - Investing.com UK

Sep 16, 2025

Street Watch: Does Santech Holdings Limited Depositary Receipt offer margin of safetyGlobal Markets & Fast Gain Swing Trade Alerts - khodrobank.com

Sep 16, 2025

Royalty Pharma (RPRX) PT Raised to $38 at UBS, But Firm on Sidelines Due to Structural Issues - StreetInsider

Sep 16, 2025